Rakuten Medical has added to its…
Rakuten Medical has added to its tally of mega-rounds, pocketing [...]
Soley Therapeutics has secured…
Soley Therapeutics has secured $200 million in series C funds, [...]
Eli Lilly has returned to Nimbus…
Eli Lilly has returned to Nimbus Therapeutics for another metabolic [...]
A pair of phase 3 psoriasis…
A pair of phase 3 psoriasis studies of Alumis’ TYK2 [...]
Instil Bio’s hopes for its…
Instil Bio’s hopes for its refreshed clinical pipeline appear to [...]
With the result falling short of…
With the result falling short of the bar Amgen set [...]
Aktis Oncology is aiming to bring…
Aktis Oncology is aiming to bring in $182 million—or more—from [...]
Sanofi has returned to U.S….
Sanofi has returned to U.S. artificial intelligence research biotech Earendil [...]
After five years, Nido Biosciences…
After five years, Nido Biosciences has reached the end of [...]
AbbVie and Gilead each used the…
AbbVie and Gilead each used the holiday season to reward [...]